Table 3. Univariate analysis of DFS and OS with breast cancer.
Risk factor | SLN metastasis | DFS | OS | |||
---|---|---|---|---|---|---|
RR (95% CI) | P | RR (95% CI) | P | RR (95% CI) | P | |
Age | 1.005 (0.990–1.020) | 0.525 | 1.009 (0.994–1.024) | 0.266 | 1.003 (0.985–1.021) | 0.765 |
Menstrual condition | 0.923 (0.571–1.492) | 0.743 | 1.110 (0.691–1.783) | 0.665 | 1.018 (0.569–1.820) | 0.953 |
Tumor size | 2.579 (1.362–4.883) | 0.004 | 1.827 (1.069–3.112) | 0.028 | 1.399 (0.685–2.856) | 0.357 |
Pathological type | 2.003 (0.979–4.098) | 0.057 | 0.667 (0.360–1.235) | 0.198 | 0.930 (0.425–2.037) | 0.857 |
TNM staging | 1.947 (1.178–3.219) | 0.009 | 1.980 (1.208–3.246) | 0.007 | 4.322 (2.392–7.809) | <0.001 |
Histological grade | 3.050 (1.786–5.211) | <0.001 | 2.448 (1.522–3.937) | <0.001 | 3.182 (1.582–6.399) | 0.001 |
Blood vessel invasion | 1.350 (0.677–2.695) | 0.394 | 2.473 (1.304-4.668) | 0.006 | 2.771 (1.391–5.520) | 0.004 |
HER-2 expression | 5.121 (3.105–8.444) | <0.001 | 2.052 (1.265–3.330) | 0.004 | 3.915 (1.949–7.865) | <0.001 |
SLN metastasis | – | – | 9.171 (4.645–18.106) | <0.001 | 3.728 (1.759–7.899) | 0.001 |
ER | 0.265 (0.154–0.456) | <0.001 | 0.571 (0.358–0.912) | 0.019 | 0.399 (0.209–0.761) | 0.005 |
PR | 0.289 (0.171–0.488) | <0.001 | 0.160 (0.097–0.265) | <0.001 | 0.534 (0.292–0.977) | 0.042 |
Abbreviations: CI, confidence interval; RR, risk ratio; –, no value.